Dipòsit Digital de Documents de la UAB 4 registres trobats  La cerca s'ha fet en 0.01 segons. 
1.
14 p, 478.1 KB Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms / Serrano-Falcón, Blanca (Hospital Clínico San Carlos (Madrid)) ; Delgado-Aros, Sílvia (Hospital del Mar (Barcelona, Catalunya)) ; Mearin, Fermín 1956- (Centro Médico Teknon) ; Ciriza de los Ríos, Constanza (Hospital Universitario 12 de Octubre (Madrid)) ; Serra Pueyo, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Mínguez, Miguel (Universitat de València) ; Montoro Huguet, Miguel (Hospital San Jorge) ; Perelló, Antonia (Hospital de Viladecans) ; Santander, Cecilio (Universidad Autónoma de Madrid) ; Pérez-Aisa, Ángeles (Agencia Sanitaria Costa del Sol) ; Bañón-Rodríguez, Inmaculada (Allergan plc) ; Rey, Enrique (Hospital Clínico San Carlos, Universidad Complutense)
Linaclotide is approved for the treatment of moderate-to-severe irritable bowel syndrome (IBS) with constipation (IBS-C) in adults. This study aimed to assess factors predictive of a clinical response and improvements in non-IBS symptoms with linaclotide treatment in a Spanish patient population. [...]
2019 - 10.1177/1756284819857358
Therapeutic Advances in Gastroenterology, Vol. 12 (august 2019)  
2.
12 p, 494.4 KB Optimizing the use of linaclotide in patients with constipation-predominant irritable bowel syndrome : an expert consensus report / Rey, Enrique (Hospital Clínico San Carlos (Madrid)) ; Mearin, Fermín 1956- (Centro Médico Teknon (Barcelona, Catalunya)) ; Alcedo, Javier (Hospital Universitario Miguel Servet (Saragossa)) ; Ciriza de los Ríos, Constanza (Hospital Universitario 12 de Octubre (Madrid)) ; Delgado-Aros, Sílvia (Neuro-Enteric Translational Science (NETS) Research Group (Barcelona, Catalunya)) ; Freitas, Teresa (Institut Hospital del Mar d'Investigacions Mèdiques) ; Mascarenhas, Miguel (CUF Porto Hospital (Porto, Portugal)) ; Mínguez, Miguel (Hospital Clínic Universitari (València)) ; Santos, Javier (Universitat Autònoma de Barcelona. Departament de Medicina) ; Serra Pueyo, Jordi (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas)
Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by chronic or recurrent abdominal pain in association with defecation or a change in bowel habits. A predominant disorder of bowel habits, IBS is classified into three main subtypes: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D) and IBS alternating between constipation and diarrhea (IBS-M). [...]
2017 - 10.1007/s12325-016-0473-8
Advances in Therapy, Vol. 34 (january 2017) , p. 587-598  
3.
59 p, 1.2 MB Acceleration of nutrient emptying from the stomach to the small bowel. A new potential mechanism to decrease caloric intake in humans / Torra Alsina, Sandra ; Delgado-Aros, Sílvia, dir. (Universitat Pompeu Fabra. Departament de Fisiologia) ; Andreu, Montserrat, dir. (Universitat Pompeu Fabra. Departament de Fisiologia) ; Solà Lamoglia, Ricard, dir. (Universitat Autònoma de Barcelona. Departament de Medicina) ; Universitat Autònoma de Barcelona. Departament de Medicina
La capacitat d'ingesta o sacietat i el seu control neuroendocrí són variables d'interès en la recerca en obesitat. No obstant això, el patró or actual per avaluar la sacietat mesura l'energia ingerida durant un bufet lliure. [...]
Acute energy intake/satiation is an outcome of interest in obesity trials as it is its neuro-endocrine control. However, the gold standard to assess satiation measures energy intake during an ad libitum buffet-meal, which is expensive and difficult to standardize across laboratories. [...]

Bellaterra : Universitat Autònoma de Barcelona, 2013  
4.
62 p, 475.3 KB Effects of glucagon-like peptide-1-(7-36)amide (GLP-1) on gastric motor function in health and diabetes : potential mechanism of action / Delgado-Aros, Sílvia ; Camilleri, Michael, dir. (Mayo Clinic Rochester)
El Glucagon-like peptide-1 (GLP-1), un pèptid derivat del processament del proglucagó en les cè_lules L del jejúnum i del colon, inhibeix la secreció àcida gàstrica i el buidament gàstric, a més de reduir la capacitat d'ingesta. [...]
Glucagon-like peptide-1 (GLP-1), a peptide derived from the processing of the proglucagon molecule in L cells of the jejunum and colon, inhibits gastric acid secretion and gastric emptying rate and it also decreases food consumption. [...]

Bellaterra : Universitat Autònoma de Barcelona, 2004  

Vegeu també: autors amb noms similars
3 Delgado-Aros, Sílvia
1 Delgado-Aros, Sílvia,
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.